Differentially Aquaporin 5 Expression in Submandibular Glands and Cerebral Cortex in Alzheimer’s Disease

dc.contributor.authorAntequera, Desiree
dc.contributor.authorCarrero, Laura
dc.contributor.authorCunha Alves, Victoria
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorHernández Gallego, Jesús
dc.contributor.authorMunicio, Cristina
dc.contributor.authorCarro, Eva
dc.date.accessioned2022-09-05T08:55:52Z
dc.date.available2022-09-05T08:55:52Z
dc.date.issued2022-07-08
dc.date.updated2022-08-16T11:18:25Z
dc.description.abstractImpaired brain clearance mechanisms may result in the accumulation of aberrant proteins that define Alzheimer's disease (AD). The water channel protein astrocytic aquaporin 4 (AQP4) is essential for brain amyloid-beta clearance, but it is known to be abnormally expressed in AD brains. The expression of AQPs is differentially regulated during diverse brain injuries, but, whereas AQP4 expression and function have been studied in AD, less is known about AQP5. AQP5 functions include not only water transport but also cell migration mediated by cytoskeleton regulation. Moreover, AQP5 has been reported to be expressed in astrocytes, which are regulated after ischemic and traumatic injury. Additionally, AQP5 is particularly abundant in the salivary glands suggesting that it may be a crucial factor in gland dysfunction associated with AD. Herein, we aim to determine whether AQP5 expression in submandibular glands and the brain was altered in AD. First, we demonstrated impaired AQP5 expression in submandibular glands in APP/PS1 mice and AD patients. Subsequently, we observed that AQP5 expression was upregulated in APP/PS1 cerebral cortex and confirmed its expression both in astrocytes and neurons. Our findings propose AQP5 as a significant role player in AD pathology, in addition to AQP4, representing a potential target for the treatment of AD.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2227-9059
dc.identifier.pmid35884950
dc.identifier.urihttps://hdl.handle.net/2445/188689
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/biomedicines10071645
dc.relation.ispartofBiomedicines, 2022, vol. 10, num. 7, p. 1645
dc.relation.urihttps://doi.org/10.3390/biomedicines10071645
dc.rightscc by (c) Antequera, Desiree et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMalaltia d'Alzheimer
dc.subject.classificationAstròcits
dc.subject.classificationEscorça cerebral
dc.subject.otherAlzheimer's disease
dc.subject.otherAstrocytes
dc.subject.otherCerebral cortex
dc.titleDifferentially Aquaporin 5 Expression in Submandibular Glands and Cerebral Cortex in Alzheimer’s Disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
biomedicines-10-01645-v2.pdf
Mida:
2.22 MB
Format:
Adobe Portable Document Format